News 2 Nov 2026 Project to develop dengue treatment pre-selected by the Global Coalition for Local and Regional Production, Innovation, and Equitable Access
Press releases 29 Oct 2026 DNDi welcomes GHIT Fund’s support for innovative approaches to improve success in Chagas disease drug discovery with Nagasaki University, the University of Dundee, and Eisai
Scientific articles 27 Oct 2026 Strengthening health systems and clinical development capacities through effective partnerships: a case study of DNDi’s collaboration with the Leishmaniasis Research and Treatment Center in Ethiopia (2003–2022) Frontiers in Tropical Diseases
Scientific articles 26 Oct 2026 Efficacy and safety of oxfendazole in adults with Trichuris spp. infection in Pemba Island, Tanzania: a double-blind, phase 2a, randomised controlled trial eClinicalMedicine
Scientific articles 22 Oct 2026 Deconvoluting the mode of action of antileishmanial aminopyrazoles through chemical mutagenesis Nature communications
Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infectious Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
Press releases 4 Jun 2008 The University of North Carolina and DNDi Agree to Synergize Novel R&D Efforts to Develop Drugs for the Most Neglected
Press releases 8 May 2008 DNDi Receives Goodwin Award for Its Social Entrepeneurial Approach for the Most Neglected
Press releases 17 Apr 2008 A Worldwide Public Partnership Makes Available a New, Once-a-Day Fixed-Dose Combination against Malaria
Press releases 6 Mar 2008 GlaxoSmithKline, Drugs for Neglected Diseases initiative to Collaborate on Research Projects to Meet Public Health Needs in the Developing World
Press releases 6 Mar 2008 Spanish government commits EUR 5 million to DNDi’s research for new medicines for neglected diseases
Press releases 12 Dec 2007 DNDi Receives $25.7M from the Bill & Melinda Gates Foundation to Develop New Medicines for Neglected Diseases
Press releases 5 Nov 2007 The US National Institutes of Health Awards DNDi with a 3-Year Grant Dedicated to the Development of a Low-Cost Treatment for Visceral Leishmaniasis
Press releases 1 Nov 2007 SCYNEXIS and DNDi Enter Landmark Multi-Year Agreement to Identify Drug Candidates to Treat Sleeping Sickness
Press releases 12 Oct 2007 DNDi Executive Team Adds Two New Directors, Including Former Abbott VP Shing Chang as New R&D Director
Press releases 11 Oct 2007 Advinus Therapeutics and DNDi Join Forces on Drug Discovery and Development for Visceral Leishmanias (Kala Azar)
Press releases 13 Jul 2007 DNDi Welcomes Marcel Tanner As Chair of the Board of Directors Along With New Chair of the Scientific Advisory Committee
Press releases 14 Jun 2006 French development agency AFD commits €1.5m to DNDi for the development of two news drugs for malaria
